Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v8-EN
Language English English
Date Updated 2021-09-15 2021-09-15
Drug Identification Number 02314932 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name Levofloxacin In 5% Dextrose Injection Levofloxacin In 5% Dextrose Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LEVOFLOXACIN LEVOFLOXACIN
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 24 x 100mL 24 x 100mL
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-31 2021-08-31
Estimated end date
Actual end date 2021-09-14 2021-09-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments